137 related articles for article (PubMed ID: 25295906)
21. Interferon-induced retinopathy and its risk in patients with diabetes and hypertension undergoing treatment for chronic hepatitis C virus infection.
Panetta JD; Gilani N
Aliment Pharmacol Ther; 2009 Sep; 30(6):597-602. PubMed ID: 19549263
[TBL] [Abstract][Full Text] [Related]
22. Taste disturbances during therapy with pegylated interferon-alpha 2b and ribavirin in patients with chronic hepatitis C.
Klimacka-Nawrot E; Musialik J; Suchecka W; Petelenz M; Hartman M; Lichtański P; Błońska-Fajfrowska B
Wiad Lek; 2010; 63(4):289-99. PubMed ID: 21608370
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts.
Tseng PL; Chen TC; Chien YS; Hung CH; Yen YH; Chang KC; Tsai MC; Lin MT; Lee CT; Shen CH; Hu TH
Am J Kidney Dis; 2013 Oct; 62(4):789-95. PubMed ID: 23746377
[TBL] [Abstract][Full Text] [Related]
24. [Acute loss of vision during therapy of chronic hepatitis C].
Salgado JP; Khoramnia R; Maier MM; Lohmann CP; Winkler von Mohrenfels C
Ophthalmologe; 2011 Jun; 108(6):561-4. PubMed ID: 21271253
[TBL] [Abstract][Full Text] [Related]
25. Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C.
Kang HM; Park MJ; Hwang JM; Kim JW; Jeong SH
Korean J Hepatol; 2009 Jun; 15(2):209-15. PubMed ID: 19581773
[TBL] [Abstract][Full Text] [Related]
26. Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients.
Callens S; Bottieau E; Michielsen P; Colebunders R
AIDS; 2004 Jan; 18(1):131. PubMed ID: 15090841
[No Abstract] [Full Text] [Related]
27. Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirin.
Farel C; Suzman DL; McLaughlin M; Campbell C; Koratich C; Masur H; Metcalf JA; Robinson MR; Polis MA; Kottilil S
AIDS; 2004 Sep; 18(13):1805-9. PubMed ID: 15316341
[TBL] [Abstract][Full Text] [Related]
28. [Anterior uveitis in a patient treated with pegylated interferon and ribavirin].
Carneros Martín JA; Fuentes Coronel A; Alvarez Delgado A; González San Martín F
Med Clin (Barc); 2003 Mar; 120(9):359. PubMed ID: 12646118
[No Abstract] [Full Text] [Related]
29. Pegylated interferon (alone or with ribavirin) for chronic hepatitis C in haemodialysis population.
Espinosa M; Hernàndez J; Arenas MD; Carnicer F; Caramelo C; Fabrizi F
Kidney Blood Press Res; 2015; 40(3):258-65. PubMed ID: 25997572
[TBL] [Abstract][Full Text] [Related]
30. Branch retinal artery occlusion and central retinal vein occlusion associated with pegylated interferon plus ribavirin combination therapy for chronic hepatitis C.
Watanabe M; Ogasawara S; Takahashi A; Takada J; Tanaka Y; Okuwaki Y; Minamino T; Hidaka H; Nakazawa T; Shibuya A; Koizumi W
Cutan Ocul Toxicol; 2012 Sep; 31(3):253-7. PubMed ID: 22172047
[TBL] [Abstract][Full Text] [Related]
31. [Acute portal thrombosis in patients with hepatitis C treated with pegylated interferon and ribavirin].
Merino Rodríguez B; Díaz Sánchez A; Matilla Peña A; Clemente Ricote G; Núñez Martínez O
Gastroenterol Hepatol; 2008 Jan; 31(1):18-21. PubMed ID: 18218275
[TBL] [Abstract][Full Text] [Related]
32. [Ischemic neuroretinopathy associated with use of interferon].
Miserachs-García S; Mesa-Toledo E; Arruga-Ginebreda J; Castillo-Campillo L
Arch Soc Esp Oftalmol; 2005 Sep; 80(9):533-5. PubMed ID: 16193437
[TBL] [Abstract][Full Text] [Related]
33. The importance of a prior psychiatric examination in pegylated interferon and ribavirin combination treatment for chronic hepatitis C.
Kuhara K; Ide T; Uchimura N; Kumashiro R; Arinaga T; Miyajima I; Murashima S; Ogata K; Kuwahara R; Amano K; Fujimoto Y; Sakai K; Ishii K; Morita Y; Shirachi M; Sata M
Kurume Med J; 2012; 59(3-4):39-44. PubMed ID: 23823013
[TBL] [Abstract][Full Text] [Related]
34. Retinal vascular complications associated with interferon-ribavirin therapy for chronic hepatitis C: A population-based study.
Lai CH; Yang YH; Chen PC; King YC; Liu CY
Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):191-198. PubMed ID: 29210149
[TBL] [Abstract][Full Text] [Related]
35. A chronic subdural hematoma in a patient receiving combination therapy with pegylated interferon alfa-2b and ribavirin for chronic hepatitis C.
Goto T; Ohshima S; Miura K; Shibuya T; Sato W; Dohmen T; Kamada K; Kanata R; Sakai T; Chiba M; Sugimoto Y; Minami S; Ohnishi H
Intern Med; 2013; 52(18):2057-60. PubMed ID: 24042512
[TBL] [Abstract][Full Text] [Related]
36. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
[TBL] [Abstract][Full Text] [Related]
37. [Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C].
Lee YN; Jeong SW; Lim JH; Ryu YS; Jeon SR; Kim SK; Jang JY; Kim YS; Kim BS; Roh MO
Korean J Hepatol; 2010 Jun; 16(2):187-91. PubMed ID: 20606504
[TBL] [Abstract][Full Text] [Related]
38. Is screening for interferon retinopathy in hepatitis C justified?
Cuthbertson FM; Davies M; McKibbin M
Br J Ophthalmol; 2004 Dec; 88(12):1518-20. PubMed ID: 15548803
[TBL] [Abstract][Full Text] [Related]
39. Expectoration of large bronchial casts secondary to the treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Araújo ES; Campos AF; Yamashiro J; Mello ES; Takagaki T; Barone AA
Clinics (Sao Paulo); 2010 Jul; 65(7):745-8. PubMed ID: 20668635
[No Abstract] [Full Text] [Related]
40. [Bilateral AION after the combined therapy of hepatitis C with PEG-interferon alpha2B and ribavirin].
Kirchhoff A; Kirchhoff U; Lafrenz M; Guthoff R
Klin Monbl Augenheilkd; 2004 Sep; 221(9):791-3. PubMed ID: 15459850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
